Protalix BioTherapeutics, Inc. (PLX) Retained Earnings (Accumulated Deficit) USD 2010 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Protalix BioTherapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2010 to 2023.
  • Protalix BioTherapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending December 31, 2023 was $382 M.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $382 M +$771 M Dec 31, 2023 10-Q 2024-05-10
Q4 2022 -$390 M -$14.9 M -3.98% Dec 31, 2022 10-K 2024-03-14
Q4 2021 -$375 M -$27.6 M -7.94% Dec 31, 2021 10-K 2023-02-27
Q4 2020 -$347 M -$6.52 M -1.91% Dec 31, 2020 10-K 2022-03-31
Q4 2019 -$341 M -$18.3 M -5.67% Dec 31, 2019 10-K 2021-03-30
Q3 2019 $341 M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $338 M Jun 30, 2019 10-Q 2019-08-08
Q4 2018 -$323 M -$26.5 M -8.94% Dec 31, 2018 10-K 2020-03-12
Q4 2017 -$296 M -$83.4 M -39.2% Dec 31, 2017 10-K 2019-03-18
Q4 2016 -$213 M -$29.4 M -16% Dec 31, 2016 10-K 2018-03-06
Q4 2015 -$183 M +$58 M +24% Dec 31, 2015 10-K 2017-03-16
Q4 2014 -$241 M -$29.9 M -14.2% Dec 31, 2014 10-K 2016-03-08
Q4 2013 -$211 M -$27.8 M -15.1% Dec 31, 2013 10-K 2015-03-12
Q4 2012 -$184 M -$11.6 M -6.76% Dec 31, 2012 10-K 2014-03-13
Q4 2011 -$172 M -$36.5 M -27% Dec 31, 2011 10-K 2013-02-28
Q4 2010 -$135 M Dec 31, 2010 10-K 2012-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.